As the industry’s technology leader in implantable hearing solutions, MED−EL products are the result of 30 years of focused research and a commitment by its founders to fostering a company culture of excellence.
MED−EL has a strong tradition of advancing the technological and scientific foundation in the field of hearing implants. The company’s strong and consistent focus on research and development will continue to fuel the pipeline of new ideas and innovations. Our broad portfolio of products ensures that we can provide a hearing implant solution to fit each candidate’s unique hearing loss.
MED−EL was there at the beginning and they will be there for you today, tomorrow and in the future offering state−of−the−art hearing implant solutions that are comfortable to wear and easy to use.
Founders Dr. Ingeborg Hochmair and Prof. Erwin Hochmair at MED-EL international headquarters in Innsbruck.
*SAMBA is pending regulatory approval.